NextGen Healthcare, Inc. (NASDAQ: NXGN) Stock Competitors & Peer Comparison
See NXGN's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Healthcare Information Services Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for NXGN and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| NXGN | $23.94 | +0.13% | 1.6B | -266.00 | -$0.09 | N/A |
| GEHC | $73.79 | +2.09% | 33.3B | 16.18 | $4.56 | +0.19% |
| GEHCV | $56.00 | -4.08% | 25.5B | N/A | N/A | N/A |
| BTSG | $60.23 | +0.92% | 11.8B | 48.57 | $1.24 | N/A |
| TEM | $54.29 | -0.59% | 9.5B | -108.58 | -$0.50 | N/A |
| SGFY | $30.49 | +0.07% | 8.9B | 70.91 | $0.43 | N/A |
| HQY | $105.59 | +0.09% | 8.8B | 24.67 | $4.28 | N/A |
| TXG | $58.15 | +0.69% | 7.4B | -342.06 | -$0.17 | N/A |
| HNGE | $87.42 | +1.27% | 6.8B | 46.68 | $1.87 | N/A |
| RCM | $14.31 | N/A | 6B | -102.21 | -$0.14 | N/A |
Stock Comparison
GE HealthCare Technologies Inc. (NASDAQ: GEHC)
NXGN vs GEHC Comparison August 2026
NextGen Healthcare, Inc. (NASDAQ: NXGN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGN stands at 1.6B. In comparison, GEHC has a market cap of 33.3B. Regarding current trading prices, NXGN is priced at $23.94 on the NASDAQ, while GEHC trades at $73.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGN currently has a P/E ratio of -266.00, whereas GEHC's P/E ratio is 16.18. In terms of profitability, NXGN's ROE is -0.01%, compared to GEHC's ROE of +0.15%. Regarding short-term risk, NXGN is less volatile compared to GEHC. This indicates lower risk in terms of short-term price fluctuations for NXGN.Check GEHC's competition here
GE HealthCare Technologies Inc. (NASDAQ: GEHCV)
NXGN vs GEHCV Comparison August 2026
NextGen Healthcare, Inc. (NASDAQ: NXGN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGN stands at 1.6B. In comparison, GEHCV has a market cap of 25.5B. Regarding current trading prices, NXGN is priced at $23.94 on the NASDAQ, while GEHCV trades at $56.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGN currently has a P/E ratio of -266.00, whereas GEHCV's P/E ratio is N/A. In terms of profitability, NXGN's ROE is -0.01%, compared to GEHCV's ROE of +0.19%. Regarding short-term risk, NXGN is less volatile compared to GEHCV. This indicates lower risk in terms of short-term price fluctuations for NXGN.Check GEHCV's competition here
BrightSpring Health Services, Inc. Common Stock (NASDAQ: BTSG)
NXGN vs BTSG Comparison August 2026
NextGen Healthcare, Inc. (NASDAQ: NXGN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGN stands at 1.6B. In comparison, BTSG has a market cap of 11.8B. Regarding current trading prices, NXGN is priced at $23.94 on the NASDAQ, while BTSG trades at $60.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGN currently has a P/E ratio of -266.00, whereas BTSG's P/E ratio is 48.57. In terms of profitability, NXGN's ROE is -0.01%, compared to BTSG's ROE of +0.15%. Regarding short-term risk, NXGN is less volatile compared to BTSG. This indicates lower risk in terms of short-term price fluctuations for NXGN.Check BTSG's competition here
Tempus AI, Inc. (NASDAQ: TEM)
NXGN vs TEM Comparison August 2026
NextGen Healthcare, Inc. (NASDAQ: NXGN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGN stands at 1.6B. In comparison, TEM has a market cap of 9.5B. Regarding current trading prices, NXGN is priced at $23.94 on the NASDAQ, while TEM trades at $54.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGN currently has a P/E ratio of -266.00, whereas TEM's P/E ratio is -108.58. In terms of profitability, NXGN's ROE is -0.01%, compared to TEM's ROE of -0.55%. Regarding short-term risk, NXGN is less volatile compared to TEM. This indicates lower risk in terms of short-term price fluctuations for NXGN.Check TEM's competition here
Signify Health, Inc. (NYSE: SGFY)
NXGN vs SGFY Comparison August 2026
NextGen Healthcare, Inc. (NASDAQ: NXGN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGN stands at 1.6B. In comparison, SGFY has a market cap of 8.9B. Regarding current trading prices, NXGN is priced at $23.94 on the NASDAQ, while SGFY trades at $30.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGN currently has a P/E ratio of -266.00, whereas SGFY's P/E ratio is 70.91. In terms of profitability, NXGN's ROE is -0.01%, compared to SGFY's ROE of -0.15%. Regarding short-term risk, NXGN is more volatile compared to SGFY. This indicates higher risk in terms of short-term price fluctuations for NXGN.Check SGFY's competition here
HealthEquity, Inc. (NASDAQ: HQY)
NXGN vs HQY Comparison August 2026
NextGen Healthcare, Inc. (NASDAQ: NXGN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGN stands at 1.6B. In comparison, HQY has a market cap of 8.8B. Regarding current trading prices, NXGN is priced at $23.94 on the NASDAQ, while HQY trades at $105.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGN currently has a P/E ratio of -266.00, whereas HQY's P/E ratio is 24.67. In terms of profitability, NXGN's ROE is -0.01%, compared to HQY's ROE of +0.11%. Regarding short-term risk, NXGN is less volatile compared to HQY. This indicates lower risk in terms of short-term price fluctuations for NXGN.Check HQY's competition here
10x Genomics, Inc. (NASDAQ: TXG)
NXGN vs TXG Comparison August 2026
NextGen Healthcare, Inc. (NASDAQ: NXGN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGN stands at 1.6B. In comparison, TXG has a market cap of 7.4B. Regarding current trading prices, NXGN is priced at $23.94 on the NASDAQ, while TXG trades at $58.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGN currently has a P/E ratio of -266.00, whereas TXG's P/E ratio is -342.06. In terms of profitability, NXGN's ROE is -0.01%, compared to TXG's ROE of -0.09%. Regarding short-term risk, NXGN is less volatile compared to TXG. This indicates lower risk in terms of short-term price fluctuations for NXGN.Check TXG's competition here
Hinge Health, Inc. (NYSE: HNGE)
NXGN vs HNGE Comparison August 2026
NextGen Healthcare, Inc. (NASDAQ: NXGN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGN stands at 1.6B. In comparison, HNGE has a market cap of 6.8B. Regarding current trading prices, NXGN is priced at $23.94 on the NASDAQ, while HNGE trades at $87.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGN currently has a P/E ratio of -266.00, whereas HNGE's P/E ratio is 46.68. In terms of profitability, NXGN's ROE is -0.01%, compared to HNGE's ROE of +0.30%. Regarding short-term risk, NXGN is less volatile compared to HNGE. This indicates lower risk in terms of short-term price fluctuations for NXGN.Check HNGE's competition here
R1 RCM Inc. (NASDAQ: RCM)
NXGN vs RCM Comparison August 2026
NextGen Healthcare, Inc. (NASDAQ: NXGN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGN stands at 1.6B. In comparison, RCM has a market cap of 6B. Regarding current trading prices, NXGN is priced at $23.94 on the NASDAQ, while RCM trades at $14.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGN currently has a P/E ratio of -266.00, whereas RCM's P/E ratio is -102.21. In terms of profitability, NXGN's ROE is -0.01%, compared to RCM's ROE of +0.00%. Regarding short-term risk, NXGN is more volatile compared to RCM. This indicates higher risk in terms of short-term price fluctuations for NXGN.Check RCM's competition here
Doximity, Inc. (NYSE: DOCS)
NXGN vs DOCS Comparison August 2026
NextGen Healthcare, Inc. (NASDAQ: NXGN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGN stands at 1.6B. In comparison, DOCS has a market cap of 5B. Regarding current trading prices, NXGN is priced at $23.94 on the NASDAQ, while DOCS trades at $26.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGN currently has a P/E ratio of -266.00, whereas DOCS's P/E ratio is 17.38. In terms of profitability, NXGN's ROE is -0.01%, compared to DOCS's ROE of +0.17%. Regarding short-term risk, NXGN is less volatile compared to DOCS. This indicates lower risk in terms of short-term price fluctuations for NXGN.Check DOCS's competition here
Waystar Holding Corp. (NASDAQ: WAY)
NXGN vs WAY Comparison August 2026
NextGen Healthcare, Inc. (NASDAQ: NXGN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGN stands at 1.6B. In comparison, WAY has a market cap of 4.8B. Regarding current trading prices, NXGN is priced at $23.94 on the NASDAQ, while WAY trades at $25.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGN currently has a P/E ratio of -266.00, whereas WAY's P/E ratio is 16.61. In terms of profitability, NXGN's ROE is -0.01%, compared to WAY's ROE of +0.04%. Regarding short-term risk, NXGN is less volatile compared to WAY. This indicates lower risk in terms of short-term price fluctuations for NXGN.Check WAY's competition here
1Life Healthcare, Inc. (NASDAQ: ONEM)
NXGN vs ONEM Comparison August 2026
NextGen Healthcare, Inc. (NASDAQ: NXGN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGN stands at 1.6B. In comparison, ONEM has a market cap of 3.4B. Regarding current trading prices, NXGN is priced at $23.94 on the NASDAQ, while ONEM trades at $16.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGN currently has a P/E ratio of -266.00, whereas ONEM's P/E ratio is -7.77. In terms of profitability, NXGN's ROE is -0.01%, compared to ONEM's ROE of -0.24%. Regarding short-term risk, NXGN is less volatile compared to ONEM. This indicates lower risk in terms of short-term price fluctuations for NXGN.Check ONEM's competition here
Privia Health Group, Inc. (NASDAQ: PRVA)
NXGN vs PRVA Comparison August 2026
NextGen Healthcare, Inc. (NASDAQ: NXGN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGN stands at 1.6B. In comparison, PRVA has a market cap of 2.7B. Regarding current trading prices, NXGN is priced at $23.94 on the NASDAQ, while PRVA trades at $21.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGN currently has a P/E ratio of -266.00, whereas PRVA's P/E ratio is 103.62. In terms of profitability, NXGN's ROE is -0.01%, compared to PRVA's ROE of +0.00%. Regarding short-term risk, NXGN is less volatile compared to PRVA. This indicates lower risk in terms of short-term price fluctuations for NXGN.Check PRVA's competition here
Heartflow, Inc. Common Stock (NASDAQ: HTFL)
NXGN vs HTFL Comparison August 2026
NextGen Healthcare, Inc. (NASDAQ: NXGN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGN stands at 1.6B. In comparison, HTFL has a market cap of 2.7B. Regarding current trading prices, NXGN is priced at $23.94 on the NASDAQ, while HTFL trades at $31.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGN currently has a P/E ratio of -266.00, whereas HTFL's P/E ratio is -15.43. In terms of profitability, NXGN's ROE is -0.01%, compared to HTFL's ROE of +8.30%. Regarding short-term risk, NXGN is less volatile compared to HTFL. This indicates lower risk in terms of short-term price fluctuations for NXGN.Check HTFL's competition here
GeneDx Holdings Corp. (NASDAQ: WGS)
NXGN vs WGS Comparison August 2026
NextGen Healthcare, Inc. (NASDAQ: NXGN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGN stands at 1.6B. In comparison, WGS has a market cap of 2.4B. Regarding current trading prices, NXGN is priced at $23.94 on the NASDAQ, while WGS trades at $79.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGN currently has a P/E ratio of -266.00, whereas WGS's P/E ratio is 219.86. In terms of profitability, NXGN's ROE is -0.01%, compared to WGS's ROE of -0.39%. Regarding short-term risk, NXGN is less volatile compared to WGS. This indicates lower risk in terms of short-term price fluctuations for NXGN.Check WGS's competition here
Progyny, Inc. (NASDAQ: PGNY)
NXGN vs PGNY Comparison August 2026
NextGen Healthcare, Inc. (NASDAQ: NXGN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGN stands at 1.6B. In comparison, PGNY has a market cap of 2B. Regarding current trading prices, NXGN is priced at $23.94 on the NASDAQ, while PGNY trades at $25.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGN currently has a P/E ratio of -266.00, whereas PGNY's P/E ratio is 18.76. In terms of profitability, NXGN's ROE is -0.01%, compared to PGNY's ROE of +0.16%. Regarding short-term risk, NXGN is less volatile compared to PGNY. This indicates lower risk in terms of short-term price fluctuations for NXGN.Check PGNY's competition here
Omada Health (NASDAQ: OMDA)
NXGN vs OMDA Comparison August 2026
NextGen Healthcare, Inc. (NASDAQ: NXGN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGN stands at 1.6B. In comparison, OMDA has a market cap of 1.4B. Regarding current trading prices, NXGN is priced at $23.94 on the NASDAQ, while OMDA trades at $24.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGN currently has a P/E ratio of -266.00, whereas OMDA's P/E ratio is 348.14. In terms of profitability, NXGN's ROE is -0.01%, compared to OMDA's ROE of +0.02%. Regarding short-term risk, NXGN is less volatile compared to OMDA. This indicates lower risk in terms of short-term price fluctuations for NXGN.Check OMDA's competition here
Agiliti, Inc. (NYSE: AGTI)
NXGN vs AGTI Comparison August 2026
NextGen Healthcare, Inc. (NASDAQ: NXGN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGN stands at 1.6B. In comparison, AGTI has a market cap of 1.4B. Regarding current trading prices, NXGN is priced at $23.94 on the NASDAQ, while AGTI trades at $10.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGN currently has a P/E ratio of -266.00, whereas AGTI's P/E ratio is -71.79. In terms of profitability, NXGN's ROE is -0.01%, compared to AGTI's ROE of -0.02%. Regarding short-term risk, NXGN is less volatile compared to AGTI. This indicates lower risk in terms of short-term price fluctuations for NXGN.Check AGTI's competition here
GoodRx Holdings, Inc. (NASDAQ: GDRX)
NXGN vs GDRX Comparison August 2026
NextGen Healthcare, Inc. (NASDAQ: NXGN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGN stands at 1.6B. In comparison, GDRX has a market cap of 1.3B. Regarding current trading prices, NXGN is priced at $23.94 on the NASDAQ, while GDRX trades at $3.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGN currently has a P/E ratio of -266.00, whereas GDRX's P/E ratio is 11.63. In terms of profitability, NXGN's ROE is -0.01%, compared to GDRX's ROE of +0.03%. Regarding short-term risk, NXGN is less volatile compared to GDRX. This indicates lower risk in terms of short-term price fluctuations for NXGN.Check GDRX's competition here
Certara, Inc. (NASDAQ: CERT)
NXGN vs CERT Comparison August 2026
NextGen Healthcare, Inc. (NASDAQ: NXGN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGN stands at 1.6B. In comparison, CERT has a market cap of 1.3B. Regarding current trading prices, NXGN is priced at $23.94 on the NASDAQ, while CERT trades at $8.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGN currently has a P/E ratio of -266.00, whereas CERT's P/E ratio is 20.38. In terms of profitability, NXGN's ROE is -0.01%, compared to CERT's ROE of -0.07%. Regarding short-term risk, NXGN is less volatile compared to CERT. This indicates lower risk in terms of short-term price fluctuations for NXGN.Check CERT's competition here
Teladoc Health, Inc. (NYSE: TDOC)
NXGN vs TDOC Comparison August 2026
NextGen Healthcare, Inc. (NASDAQ: NXGN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGN stands at 1.6B. In comparison, TDOC has a market cap of 1.3B. Regarding current trading prices, NXGN is priced at $23.94 on the NASDAQ, while TDOC trades at $6.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGN currently has a P/E ratio of -266.00, whereas TDOC's P/E ratio is -7.72. In terms of profitability, NXGN's ROE is -0.01%, compared to TDOC's ROE of -0.13%. Regarding short-term risk, NXGN is less volatile compared to TDOC. This indicates lower risk in terms of short-term price fluctuations for NXGN.Check TDOC's competition here
CareCloud, Inc. (NASDAQ: CCLDO)
NXGN vs CCLDO Comparison August 2026
NextGen Healthcare, Inc. (NASDAQ: NXGN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGN stands at 1.6B. In comparison, CCLDO has a market cap of 857.3M. Regarding current trading prices, NXGN is priced at $23.94 on the NASDAQ, while CCLDO trades at $27.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGN currently has a P/E ratio of -266.00, whereas CCLDO's P/E ratio is N/A. In terms of profitability, NXGN's ROE is -0.01%, compared to CCLDO's ROE of +0.17%. Regarding short-term risk, NXGN is more volatile compared to CCLDO. This indicates higher risk in terms of short-term price fluctuations for NXGN.Check CCLDO's competition here
HealthStream, Inc. (NASDAQ: HSTM)
NXGN vs HSTM Comparison August 2026
NextGen Healthcare, Inc. (NASDAQ: NXGN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGN stands at 1.6B. In comparison, HSTM has a market cap of 847.8M. Regarding current trading prices, NXGN is priced at $23.94 on the NASDAQ, while HSTM trades at $29.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGN currently has a P/E ratio of -266.00, whereas HSTM's P/E ratio is 35.83. In terms of profitability, NXGN's ROE is -0.01%, compared to HSTM's ROE of +0.06%. Regarding short-term risk, NXGN is less volatile compared to HSTM. This indicates lower risk in terms of short-term price fluctuations for NXGN.Check HSTM's competition here
Phreesia, Inc. (NYSE: PHR)
NXGN vs PHR Comparison August 2026
NextGen Healthcare, Inc. (NASDAQ: NXGN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGN stands at 1.6B. In comparison, PHR has a market cap of 779.4M. Regarding current trading prices, NXGN is priced at $23.94 on the NASDAQ, while PHR trades at $12.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGN currently has a P/E ratio of -266.00, whereas PHR's P/E ratio is 45.04. In terms of profitability, NXGN's ROE is -0.01%, compared to PHR's ROE of +0.03%. Regarding short-term risk, NXGN is less volatile compared to PHR. This indicates lower risk in terms of short-term price fluctuations for NXGN.Check PHR's competition here
Claritev Corporation (NYSE: CTEV)
NXGN vs CTEV Comparison August 2026
NextGen Healthcare, Inc. (NASDAQ: NXGN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGN stands at 1.6B. In comparison, CTEV has a market cap of 719.4M. Regarding current trading prices, NXGN is priced at $23.94 on the NASDAQ, while CTEV trades at $42.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGN currently has a P/E ratio of -266.00, whereas CTEV's P/E ratio is -2.48. In terms of profitability, NXGN's ROE is -0.01%, compared to CTEV's ROE of +1.40%. Regarding short-term risk, NXGN is less volatile compared to CTEV. This indicates lower risk in terms of short-term price fluctuations for NXGN.Check CTEV's competition here
SOPHiA GENETICS S.A. (NASDAQ: SOPH)
NXGN vs SOPH Comparison August 2026
NextGen Healthcare, Inc. (NASDAQ: NXGN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGN stands at 1.6B. In comparison, SOPH has a market cap of 639.3M. Regarding current trading prices, NXGN is priced at $23.94 on the NASDAQ, while SOPH trades at $7.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGN currently has a P/E ratio of -266.00, whereas SOPH's P/E ratio is -6.86. In terms of profitability, NXGN's ROE is -0.01%, compared to SOPH's ROE of -1.37%. Regarding short-term risk, NXGN is less volatile compared to SOPH. This indicates lower risk in terms of short-term price fluctuations for NXGN.Check SOPH's competition here
MultiPlan Corporation (NYSE: MPLN-WT)
NXGN vs MPLN-WT Comparison August 2026
NextGen Healthcare, Inc. (NASDAQ: NXGN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGN stands at 1.6B. In comparison, MPLN-WT has a market cap of 625.2M. Regarding current trading prices, NXGN is priced at $23.94 on the NASDAQ, while MPLN-WT trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGN currently has a P/E ratio of -266.00, whereas MPLN-WT's P/E ratio is N/A. In terms of profitability, NXGN's ROE is -0.01%, compared to MPLN-WT's ROE of +1.40%. Regarding short-term risk, NXGN is less volatile compared to MPLN-WT. This indicates lower risk in terms of short-term price fluctuations for NXGN.Check MPLN-WT's competition here
Accolade, Inc. (NASDAQ: ACCD)
NXGN vs ACCD Comparison August 2026
NextGen Healthcare, Inc. (NASDAQ: NXGN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGN stands at 1.6B. In comparison, ACCD has a market cap of 575.6M. Regarding current trading prices, NXGN is priced at $23.94 on the NASDAQ, while ACCD trades at $7.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGN currently has a P/E ratio of -266.00, whereas ACCD's P/E ratio is -3.08. In terms of profitability, NXGN's ROE is -0.01%, compared to ACCD's ROE of -0.22%. Regarding short-term risk, NXGN is more volatile compared to ACCD. This indicates higher risk in terms of short-term price fluctuations for NXGN.Check ACCD's competition here
Sharecare, Inc. (NASDAQ: SHCR)
NXGN vs SHCR Comparison August 2026
NextGen Healthcare, Inc. (NASDAQ: NXGN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGN stands at 1.6B. In comparison, SHCR has a market cap of 531.8M. Regarding current trading prices, NXGN is priced at $23.94 on the NASDAQ, while SHCR trades at $1.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGN currently has a P/E ratio of -266.00, whereas SHCR's P/E ratio is -3.76. In terms of profitability, NXGN's ROE is -0.01%, compared to SHCR's ROE of -0.25%. Regarding short-term risk, NXGN is less volatile compared to SHCR. This indicates lower risk in terms of short-term price fluctuations for NXGN.Check SHCR's competition here
Evolent Health, Inc. (NYSE: EVH)
NXGN vs EVH Comparison August 2026
NextGen Healthcare, Inc. (NASDAQ: NXGN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGN stands at 1.6B. In comparison, EVH has a market cap of 525.3M. Regarding current trading prices, NXGN is priced at $23.94 on the NASDAQ, while EVH trades at $4.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGN currently has a P/E ratio of -266.00, whereas EVH's P/E ratio is 35.92. In terms of profitability, NXGN's ROE is -0.01%, compared to EVH's ROE of -0.99%. Regarding short-term risk, NXGN is less volatile compared to EVH. This indicates lower risk in terms of short-term price fluctuations for NXGN.Check EVH's competition here
NRC Health (NASDAQ: NRC)
NXGN vs NRC Comparison August 2026
NextGen Healthcare, Inc. (NASDAQ: NXGN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGN stands at 1.6B. In comparison, NRC has a market cap of 480.3M. Regarding current trading prices, NXGN is priced at $23.94 on the NASDAQ, while NRC trades at $21.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGN currently has a P/E ratio of -266.00, whereas NRC's P/E ratio is 25.99. In terms of profitability, NXGN's ROE is -0.01%, compared to NRC's ROE of +0.48%. Regarding short-term risk, NXGN is less volatile compared to NRC. This indicates lower risk in terms of short-term price fluctuations for NXGN.Check NRC's competition here
SomaLogic, Inc. (NASDAQ: SLGC)
NXGN vs SLGC Comparison August 2026
NextGen Healthcare, Inc. (NASDAQ: NXGN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGN stands at 1.6B. In comparison, SLGC has a market cap of 396.2M. Regarding current trading prices, NXGN is priced at $23.94 on the NASDAQ, while SLGC trades at $2.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGN currently has a P/E ratio of -266.00, whereas SLGC's P/E ratio is -3.04. In terms of profitability, NXGN's ROE is -0.01%, compared to SLGC's ROE of -0.19%. Regarding short-term risk, NXGN is less volatile compared to SLGC. This indicates lower risk in terms of short-term price fluctuations for NXGN.Check SLGC's competition here
SomaLogic, Inc. (NASDAQ: SLGCW)
NXGN vs SLGCW Comparison August 2026
NextGen Healthcare, Inc. (NASDAQ: NXGN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGN stands at 1.6B. In comparison, SLGCW has a market cap of 396.2M. Regarding current trading prices, NXGN is priced at $23.94 on the NASDAQ, while SLGCW trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGN currently has a P/E ratio of -266.00, whereas SLGCW's P/E ratio is -0.16. In terms of profitability, NXGN's ROE is -0.01%, compared to SLGCW's ROE of -0.19%. Regarding short-term risk, NXGN is less volatile compared to SLGCW. This indicates lower risk in terms of short-term price fluctuations for NXGN.Check SLGCW's competition here
TruBridge, Inc. (NASDAQ: TBRG)
NXGN vs TBRG Comparison August 2026
NextGen Healthcare, Inc. (NASDAQ: NXGN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGN stands at 1.6B. In comparison, TBRG has a market cap of 393.6M. Regarding current trading prices, NXGN is priced at $23.94 on the NASDAQ, while TBRG trades at $26.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGN currently has a P/E ratio of -266.00, whereas TBRG's P/E ratio is 9.37. In terms of profitability, NXGN's ROE is -0.01%, compared to TBRG's ROE of +0.02%. Regarding short-term risk, NXGN is more volatile compared to TBRG. This indicates higher risk in terms of short-term price fluctuations for NXGN.Check TBRG's competition here
MultiPlan Corporation (NYSE: MPLN)
NXGN vs MPLN Comparison August 2026
NextGen Healthcare, Inc. (NASDAQ: NXGN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGN stands at 1.6B. In comparison, MPLN has a market cap of 375M. Regarding current trading prices, NXGN is priced at $23.94 on the NASDAQ, while MPLN trades at $23.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGN currently has a P/E ratio of -266.00, whereas MPLN's P/E ratio is -0.23. In terms of profitability, NXGN's ROE is -0.01%, compared to MPLN's ROE of +1.40%. Regarding short-term risk, NXGN is less volatile compared to MPLN. This indicates lower risk in terms of short-term price fluctuations for NXGN.Check MPLN's competition here
So-Young International Inc. (NASDAQ: SY)
NXGN vs SY Comparison August 2026
NextGen Healthcare, Inc. (NASDAQ: NXGN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGN stands at 1.6B. In comparison, SY has a market cap of 288.7M. Regarding current trading prices, NXGN is priced at $23.94 on the NASDAQ, while SY trades at $2.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGN currently has a P/E ratio of -266.00, whereas SY's P/E ratio is -6.67. In terms of profitability, NXGN's ROE is -0.01%, compared to SY's ROE of -0.16%. Regarding short-term risk, NXGN is less volatile compared to SY. This indicates lower risk in terms of short-term price fluctuations for NXGN.Check SY's competition here
Tabula Rasa HealthCare, Inc. (NASDAQ: TRHC)
NXGN vs TRHC Comparison August 2026
NextGen Healthcare, Inc. (NASDAQ: NXGN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGN stands at 1.6B. In comparison, TRHC has a market cap of 284M. Regarding current trading prices, NXGN is priced at $23.94 on the NASDAQ, while TRHC trades at $10.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGN currently has a P/E ratio of -266.00, whereas TRHC's P/E ratio is -4.27. In terms of profitability, NXGN's ROE is -0.01%, compared to TRHC's ROE of +121.31%. Regarding short-term risk, NXGN is less volatile compared to TRHC. This indicates lower risk in terms of short-term price fluctuations for NXGN.Check TRHC's competition here
Sema4 Holdings Corp. (NASDAQ: SMFR)
NXGN vs SMFR Comparison August 2026
NextGen Healthcare, Inc. (NASDAQ: NXGN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGN stands at 1.6B. In comparison, SMFR has a market cap of 246.4M. Regarding current trading prices, NXGN is priced at $23.94 on the NASDAQ, while SMFR trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGN currently has a P/E ratio of -266.00, whereas SMFR's P/E ratio is N/A. In terms of profitability, NXGN's ROE is -0.01%, compared to SMFR's ROE of -0.39%. Regarding short-term risk, NXGN is less volatile compared to SMFR. This indicates lower risk in terms of short-term price fluctuations for NXGN.Check SMFR's competition here
Spok Holdings, Inc. (NASDAQ: SPOK)
NXGN vs SPOK Comparison August 2026
NextGen Healthcare, Inc. (NASDAQ: NXGN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGN stands at 1.6B. In comparison, SPOK has a market cap of 229.8M. Regarding current trading prices, NXGN is priced at $23.94 on the NASDAQ, while SPOK trades at $11.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGN currently has a P/E ratio of -266.00, whereas SPOK's P/E ratio is 18.33. In terms of profitability, NXGN's ROE is -0.01%, compared to SPOK's ROE of +0.09%. Regarding short-term risk, NXGN is less volatile compared to SPOK. This indicates lower risk in terms of short-term price fluctuations for NXGN.Check SPOK's competition here
American Well Corporation (NYSE: AMWL)
NXGN vs AMWL Comparison August 2026
NextGen Healthcare, Inc. (NASDAQ: NXGN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGN stands at 1.6B. In comparison, AMWL has a market cap of 219.9M. Regarding current trading prices, NXGN is priced at $23.94 on the NASDAQ, while AMWL trades at $12.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGN currently has a P/E ratio of -266.00, whereas AMWL's P/E ratio is -2.93. In terms of profitability, NXGN's ROE is -0.01%, compared to AMWL's ROE of -0.33%. Regarding short-term risk, NXGN is less volatile compared to AMWL. This indicates lower risk in terms of short-term price fluctuations for NXGN.Check AMWL's competition here
OptimizeRx Corp. (NASDAQ: OPRX)
NXGN vs OPRX Comparison August 2026
NextGen Healthcare, Inc. (NASDAQ: NXGN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGN stands at 1.6B. In comparison, OPRX has a market cap of 164.8M. Regarding current trading prices, NXGN is priced at $23.94 on the NASDAQ, while OPRX trades at $8.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGN currently has a P/E ratio of -266.00, whereas OPRX's P/E ratio is 8.06. In terms of profitability, NXGN's ROE is -0.01%, compared to OPRX's ROE of +0.04%. Regarding short-term risk, NXGN is less volatile compared to OPRX. This indicates lower risk in terms of short-term price fluctuations for NXGN.Check OPRX's competition here
Computer Programs and Systems, Inc. (NASDAQ: CPSI)
NXGN vs CPSI Comparison August 2026
NextGen Healthcare, Inc. (NASDAQ: NXGN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGN stands at 1.6B. In comparison, CPSI has a market cap of 133.7M. Regarding current trading prices, NXGN is priced at $23.94 on the NASDAQ, while CPSI trades at $9.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGN currently has a P/E ratio of -266.00, whereas CPSI's P/E ratio is -183.80. In terms of profitability, NXGN's ROE is -0.01%, compared to CPSI's ROE of +0.02%. Regarding short-term risk, NXGN is less volatile compared to CPSI. This indicates lower risk in terms of short-term price fluctuations for NXGN.Check CPSI's competition here
Health Catalyst, Inc. (NASDAQ: HCAT)
NXGN vs HCAT Comparison August 2026
NextGen Healthcare, Inc. (NASDAQ: NXGN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGN stands at 1.6B. In comparison, HCAT has a market cap of 129.3M. Regarding current trading prices, NXGN is priced at $23.94 on the NASDAQ, while HCAT trades at $1.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGN currently has a P/E ratio of -266.00, whereas HCAT's P/E ratio is 8.75. In terms of profitability, NXGN's ROE is -0.01%, compared to HCAT's ROE of -1.30%. Regarding short-term risk, NXGN is less volatile compared to HCAT. This indicates lower risk in terms of short-term price fluctuations for NXGN.Check HCAT's competition here
Augmedix, Inc. (NASDAQ: AUGX)
NXGN vs AUGX Comparison August 2026
NextGen Healthcare, Inc. (NASDAQ: NXGN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGN stands at 1.6B. In comparison, AUGX has a market cap of 115.9M. Regarding current trading prices, NXGN is priced at $23.94 on the NASDAQ, while AUGX trades at $2.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGN currently has a P/E ratio of -266.00, whereas AUGX's P/E ratio is -4.99. In terms of profitability, NXGN's ROE is -0.01%, compared to AUGX's ROE of -1.55%. Regarding short-term risk, NXGN is less volatile compared to AUGX. This indicates lower risk in terms of short-term price fluctuations for NXGN.Check AUGX's competition here
CareCloud, Inc. (NASDAQ: CCLD)
NXGN vs CCLD Comparison August 2026
NextGen Healthcare, Inc. (NASDAQ: NXGN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGN stands at 1.6B. In comparison, CCLD has a market cap of 104.1M. Regarding current trading prices, NXGN is priced at $23.94 on the NASDAQ, while CCLD trades at $2.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGN currently has a P/E ratio of -266.00, whereas CCLD's P/E ratio is 9.42. In terms of profitability, NXGN's ROE is -0.01%, compared to CCLD's ROE of +0.17%. Regarding short-term risk, NXGN is less volatile compared to CCLD. This indicates lower risk in terms of short-term price fluctuations for NXGN.Check CCLD's competition here
SCWorx Corp. (NASDAQ: WORX)
NXGN vs WORX Comparison August 2026
NextGen Healthcare, Inc. (NASDAQ: NXGN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGN stands at 1.6B. In comparison, WORX has a market cap of 88M. Regarding current trading prices, NXGN is priced at $23.94 on the NASDAQ, while WORX trades at $5.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGN currently has a P/E ratio of -266.00, whereas WORX's P/E ratio is -6.40. In terms of profitability, NXGN's ROE is -0.01%, compared to WORX's ROE of -0.65%. Regarding short-term risk, NXGN is less volatile compared to WORX. This indicates lower risk in terms of short-term price fluctuations for NXGN.Check WORX's competition here
Forian Inc. (NASDAQ: FORA)
NXGN vs FORA Comparison August 2026
NextGen Healthcare, Inc. (NASDAQ: NXGN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGN stands at 1.6B. In comparison, FORA has a market cap of 67.8M. Regarding current trading prices, NXGN is priced at $23.94 on the NASDAQ, while FORA trades at $2.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGN currently has a P/E ratio of -266.00, whereas FORA's P/E ratio is -24.11. In terms of profitability, NXGN's ROE is -0.01%, compared to FORA's ROE of -0.17%. Regarding short-term risk, NXGN is more volatile compared to FORA. This indicates higher risk in terms of short-term price fluctuations for NXGN.Check FORA's competition here
Definitive Healthcare Corp. (NASDAQ: DH)
NXGN vs DH Comparison August 2026
NextGen Healthcare, Inc. (NASDAQ: NXGN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGN stands at 1.6B. In comparison, DH has a market cap of 67.6M. Regarding current trading prices, NXGN is priced at $23.94 on the NASDAQ, while DH trades at $0.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGN currently has a P/E ratio of -266.00, whereas DH's P/E ratio is 2.46. In terms of profitability, NXGN's ROE is -0.01%, compared to DH's ROE of -0.75%. Regarding short-term risk, NXGN is less volatile compared to DH. This indicates lower risk in terms of short-term price fluctuations for NXGN.Check DH's competition here
CareCloud, Inc. (NASDAQ: CCLDP)
NXGN vs CCLDP Comparison August 2026
NextGen Healthcare, Inc. (NASDAQ: NXGN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGN stands at 1.6B. In comparison, CCLDP has a market cap of 59.9M. Regarding current trading prices, NXGN is priced at $23.94 on the NASDAQ, while CCLDP trades at $19.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGN currently has a P/E ratio of -266.00, whereas CCLDP's P/E ratio is N/A. In terms of profitability, NXGN's ROE is -0.01%, compared to CCLDP's ROE of +0.17%. Regarding short-term risk, NXGN is less volatile compared to CCLDP. This indicates lower risk in terms of short-term price fluctuations for NXGN.Check CCLDP's competition here
OneMedNet Corporation (NASDAQ: ONMD)
NXGN vs ONMD Comparison August 2026
NextGen Healthcare, Inc. (NASDAQ: NXGN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGN stands at 1.6B. In comparison, ONMD has a market cap of 44.3M. Regarding current trading prices, NXGN is priced at $23.94 on the NASDAQ, while ONMD trades at $0.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGN currently has a P/E ratio of -266.00, whereas ONMD's P/E ratio is -5.18. In terms of profitability, NXGN's ROE is -0.01%, compared to ONMD's ROE of +0.90%. Regarding short-term risk, NXGN is less volatile compared to ONMD. This indicates lower risk in terms of short-term price fluctuations for NXGN.Check ONMD's competition here
Science 37 Holdings, Inc. (NASDAQ: SNCE)
NXGN vs SNCE Comparison August 2026
NextGen Healthcare, Inc. (NASDAQ: NXGN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGN stands at 1.6B. In comparison, SNCE has a market cap of 34.7M. Regarding current trading prices, NXGN is priced at $23.94 on the NASDAQ, while SNCE trades at $5.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGN currently has a P/E ratio of -266.00, whereas SNCE's P/E ratio is -0.27. In terms of profitability, NXGN's ROE is -0.01%, compared to SNCE's ROE of -0.47%. Regarding short-term risk, NXGN is less volatile compared to SNCE. This indicates lower risk in terms of short-term price fluctuations for NXGN.Check SNCE's competition here
Akili, Inc. (NASDAQ: AKLI)
NXGN vs AKLI Comparison August 2026
NextGen Healthcare, Inc. (NASDAQ: NXGN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGN stands at 1.6B. In comparison, AKLI has a market cap of 34.1M. Regarding current trading prices, NXGN is priced at $23.94 on the NASDAQ, while AKLI trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGN currently has a P/E ratio of -266.00, whereas AKLI's P/E ratio is -0.71. In terms of profitability, NXGN's ROE is -0.01%, compared to AKLI's ROE of -0.70%. Regarding short-term risk, NXGN is less volatile compared to AKLI. This indicates lower risk in terms of short-term price fluctuations for NXGN.Check AKLI's competition here
SHL Telemedicine Ltd. (NASDAQ: SHLT)
NXGN vs SHLT Comparison August 2026
NextGen Healthcare, Inc. (NASDAQ: NXGN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGN stands at 1.6B. In comparison, SHLT has a market cap of 33.6M. Regarding current trading prices, NXGN is priced at $23.94 on the NASDAQ, while SHLT trades at $2.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGN currently has a P/E ratio of -266.00, whereas SHLT's P/E ratio is -3.87. In terms of profitability, NXGN's ROE is -0.01%, compared to SHLT's ROE of -0.50%. Regarding short-term risk, NXGN is more volatile compared to SHLT. This indicates higher risk in terms of short-term price fluctuations for NXGN.Check SHLT's competition here
Sharecare, Inc. (NASDAQ: SHCRW)
NXGN vs SHCRW Comparison August 2026
NextGen Healthcare, Inc. (NASDAQ: NXGN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGN stands at 1.6B. In comparison, SHCRW has a market cap of 32.5M. Regarding current trading prices, NXGN is priced at $23.94 on the NASDAQ, while SHCRW trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGN currently has a P/E ratio of -266.00, whereas SHCRW's P/E ratio is -0.00. In terms of profitability, NXGN's ROE is -0.01%, compared to SHCRW's ROE of -0.25%. Regarding short-term risk, NXGN is less volatile compared to SHCRW. This indicates lower risk in terms of short-term price fluctuations for NXGN.Check SHCRW's competition here
OneMedNet Corporation (NASDAQ: ONMDW)
NXGN vs ONMDW Comparison August 2026
NextGen Healthcare, Inc. (NASDAQ: NXGN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGN stands at 1.6B. In comparison, ONMDW has a market cap of 32M. Regarding current trading prices, NXGN is priced at $23.94 on the NASDAQ, while ONMDW trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGN currently has a P/E ratio of -266.00, whereas ONMDW's P/E ratio is N/A. In terms of profitability, NXGN's ROE is -0.01%, compared to ONMDW's ROE of +0.90%. Regarding short-term risk, NXGN is less volatile compared to ONMDW. This indicates lower risk in terms of short-term price fluctuations for NXGN.Check ONMDW's competition here
Streamline Health Solutions, Inc. (NASDAQ: STRM)
NXGN vs STRM Comparison August 2026
NextGen Healthcare, Inc. (NASDAQ: NXGN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGN stands at 1.6B. In comparison, STRM has a market cap of 23.2M. Regarding current trading prices, NXGN is priced at $23.94 on the NASDAQ, while STRM trades at $5.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGN currently has a P/E ratio of -266.00, whereas STRM's P/E ratio is -2.40. In terms of profitability, NXGN's ROE is -0.01%, compared to STRM's ROE of -0.65%. Regarding short-term risk, NXGN is more volatile compared to STRM. This indicates higher risk in terms of short-term price fluctuations for NXGN.Check STRM's competition here
Renalytix Plc (NASDAQ: RNLX)
NXGN vs RNLX Comparison August 2026
NextGen Healthcare, Inc. (NASDAQ: NXGN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGN stands at 1.6B. In comparison, RNLX has a market cap of 22.5M. Regarding current trading prices, NXGN is priced at $23.94 on the NASDAQ, while RNLX trades at $0.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGN currently has a P/E ratio of -266.00, whereas RNLX's P/E ratio is -0.33. In terms of profitability, NXGN's ROE is -0.01%, compared to RNLX's ROE of -6.31%. Regarding short-term risk, NXGN is less volatile compared to RNLX. This indicates lower risk in terms of short-term price fluctuations for NXGN.Check RNLX's competition here
MSP Recovery, Inc. (NASDAQ: LIFW)
NXGN vs LIFW Comparison August 2026
NextGen Healthcare, Inc. (NASDAQ: NXGN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGN stands at 1.6B. In comparison, LIFW has a market cap of 22.4M. Regarding current trading prices, NXGN is priced at $23.94 on the NASDAQ, while LIFW trades at $3.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGN currently has a P/E ratio of -266.00, whereas LIFW's P/E ratio is -0.02. In terms of profitability, NXGN's ROE is -0.01%, compared to LIFW's ROE of +1.56%. Regarding short-term risk, NXGN is more volatile compared to LIFW. This indicates higher risk in terms of short-term price fluctuations for NXGN.Check LIFW's competition here
Scienture Holdings, Inc. (NASDAQ: SCNX)
NXGN vs SCNX Comparison August 2026
NextGen Healthcare, Inc. (NASDAQ: NXGN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGN stands at 1.6B. In comparison, SCNX has a market cap of 18.9M. Regarding current trading prices, NXGN is priced at $23.94 on the NASDAQ, while SCNX trades at $0.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGN currently has a P/E ratio of -266.00, whereas SCNX's P/E ratio is -0.19. In terms of profitability, NXGN's ROE is -0.01%, compared to SCNX's ROE of -0.00%. Regarding short-term risk, NXGN is less volatile compared to SCNX. This indicates lower risk in terms of short-term price fluctuations for NXGN.Check SCNX's competition here
Babylon Holdings Limited (NYSE: BBLN)
NXGN vs BBLN Comparison August 2026
NextGen Healthcare, Inc. (NASDAQ: NXGN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGN stands at 1.6B. In comparison, BBLN has a market cap of 14.1M. Regarding current trading prices, NXGN is priced at $23.94 on the NASDAQ, while BBLN trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGN currently has a P/E ratio of -266.00, whereas BBLN's P/E ratio is -0.04. In terms of profitability, NXGN's ROE is -0.01%, compared to BBLN's ROE of +4.89%. Regarding short-term risk, NXGN is less volatile compared to BBLN. This indicates lower risk in terms of short-term price fluctuations for NXGN.Check BBLN's competition here
HeartBeam, Inc. (NASDAQ: BEATW)
NXGN vs BEATW Comparison August 2026
NextGen Healthcare, Inc. (NASDAQ: NXGN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGN stands at 1.6B. In comparison, BEATW has a market cap of 12.5M. Regarding current trading prices, NXGN is priced at $23.94 on the NASDAQ, while BEATW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGN currently has a P/E ratio of -266.00, whereas BEATW's P/E ratio is -0.03. In terms of profitability, NXGN's ROE is -0.01%, compared to BEATW's ROE of -10.34%. Regarding short-term risk, NXGN is more volatile compared to BEATW. This indicates higher risk in terms of short-term price fluctuations for NXGN.Check BEATW's competition here
Bullfrog AI Holdings, Inc. Common Stock (NASDAQ: BFRG)
NXGN vs BFRG Comparison August 2026
NextGen Healthcare, Inc. (NASDAQ: NXGN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGN stands at 1.6B. In comparison, BFRG has a market cap of 10.8M. Regarding current trading prices, NXGN is priced at $23.94 on the NASDAQ, while BFRG trades at $0.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGN currently has a P/E ratio of -266.00, whereas BFRG's P/E ratio is -1.08. In terms of profitability, NXGN's ROE is -0.01%, compared to BFRG's ROE of -2.18%. Regarding short-term risk, NXGN is less volatile compared to BFRG. This indicates lower risk in terms of short-term price fluctuations for NXGN.Check BFRG's competition here
ETAO International Co., Ltd. (NASDAQ: ETAO)
NXGN vs ETAO Comparison August 2026
NextGen Healthcare, Inc. (NASDAQ: NXGN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGN stands at 1.6B. In comparison, ETAO has a market cap of 9.8M. Regarding current trading prices, NXGN is priced at $23.94 on the NASDAQ, while ETAO trades at $1.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGN currently has a P/E ratio of -266.00, whereas ETAO's P/E ratio is -0.01. In terms of profitability, NXGN's ROE is -0.01%, compared to ETAO's ROE of -13.69%. Regarding short-term risk, NXGN is less volatile compared to ETAO. This indicates lower risk in terms of short-term price fluctuations for NXGN.Check ETAO's competition here
Mangoceuticals, Inc. (NASDAQ: MGRX)
NXGN vs MGRX Comparison August 2026
NextGen Healthcare, Inc. (NASDAQ: NXGN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGN stands at 1.6B. In comparison, MGRX has a market cap of 9M. Regarding current trading prices, NXGN is priced at $23.94 on the NASDAQ, while MGRX trades at $0.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGN currently has a P/E ratio of -266.00, whereas MGRX's P/E ratio is -0.39. In terms of profitability, NXGN's ROE is -0.01%, compared to MGRX's ROE of -1.21%. Regarding short-term risk, NXGN is less volatile compared to MGRX. This indicates lower risk in terms of short-term price fluctuations for NXGN.Check MGRX's competition here
UpHealth, Inc. (NYSE: UPH)
NXGN vs UPH Comparison August 2026
NextGen Healthcare, Inc. (NASDAQ: NXGN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGN stands at 1.6B. In comparison, UPH has a market cap of 5.3M. Regarding current trading prices, NXGN is priced at $23.94 on the NASDAQ, while UPH trades at $0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGN currently has a P/E ratio of -266.00, whereas UPH's P/E ratio is -0.07. In terms of profitability, NXGN's ROE is -0.01%, compared to UPH's ROE of -1.05%. Regarding short-term risk, NXGN is less volatile compared to UPH. This indicates lower risk in terms of short-term price fluctuations for NXGN.Check UPH's competition here
UpHealth, Inc. (NYSE: UPH-WT)
NXGN vs UPH-WT Comparison August 2026
NextGen Healthcare, Inc. (NASDAQ: NXGN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGN stands at 1.6B. In comparison, UPH-WT has a market cap of 5.3M. Regarding current trading prices, NXGN is priced at $23.94 on the NASDAQ, while UPH-WT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGN currently has a P/E ratio of -266.00, whereas UPH-WT's P/E ratio is N/A. In terms of profitability, NXGN's ROE is -0.01%, compared to UPH-WT's ROE of -1.05%. Regarding short-term risk, NXGN is less volatile compared to UPH-WT. This indicates lower risk in terms of short-term price fluctuations for NXGN.Check UPH-WT's competition here
Pear Therapeutics, Inc. (NASDAQ: PEAR)
NXGN vs PEAR Comparison August 2026
NextGen Healthcare, Inc. (NASDAQ: NXGN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGN stands at 1.6B. In comparison, PEAR has a market cap of 4.1M. Regarding current trading prices, NXGN is priced at $23.94 on the NASDAQ, while PEAR trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGN currently has a P/E ratio of -266.00, whereas PEAR's P/E ratio is -0.08. In terms of profitability, NXGN's ROE is -0.01%, compared to PEAR's ROE of -0.39%. Regarding short-term risk, NXGN is less volatile compared to PEAR. This indicates lower risk in terms of short-term price fluctuations for NXGN.Check PEAR's competition here
Pear Therapeutics, Inc. (NASDAQ: PEARW)
NXGN vs PEARW Comparison August 2026
NextGen Healthcare, Inc. (NASDAQ: NXGN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGN stands at 1.6B. In comparison, PEARW has a market cap of 4.1M. Regarding current trading prices, NXGN is priced at $23.94 on the NASDAQ, while PEARW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGN currently has a P/E ratio of -266.00, whereas PEARW's P/E ratio is -0.00. In terms of profitability, NXGN's ROE is -0.01%, compared to PEARW's ROE of -0.39%. Regarding short-term risk, NXGN is less volatile compared to PEARW. This indicates lower risk in terms of short-term price fluctuations for NXGN.Check PEARW's competition here
Ontrak, Inc. (NASDAQ: OTRK)
NXGN vs OTRK Comparison August 2026
NextGen Healthcare, Inc. (NASDAQ: NXGN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGN stands at 1.6B. In comparison, OTRK has a market cap of 2.3M. Regarding current trading prices, NXGN is priced at $23.94 on the NASDAQ, while OTRK trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGN currently has a P/E ratio of -266.00, whereas OTRK's P/E ratio is -0.02. In terms of profitability, NXGN's ROE is -0.01%, compared to OTRK's ROE of -2.11%. Regarding short-term risk, NXGN is more volatile compared to OTRK. This indicates higher risk in terms of short-term price fluctuations for NXGN.Check OTRK's competition here
Healthcare Triangle, Inc. (NASDAQ: HCTI)
NXGN vs HCTI Comparison August 2026
NextGen Healthcare, Inc. (NASDAQ: NXGN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGN stands at 1.6B. In comparison, HCTI has a market cap of 2M. Regarding current trading prices, NXGN is priced at $23.94 on the NASDAQ, while HCTI trades at $1.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGN currently has a P/E ratio of -266.00, whereas HCTI's P/E ratio is -0.22. In terms of profitability, NXGN's ROE is -0.01%, compared to HCTI's ROE of -0.68%. Regarding short-term risk, NXGN is less volatile compared to HCTI. This indicates lower risk in terms of short-term price fluctuations for NXGN.Check HCTI's competition here
CareMax, Inc. (NASDAQ: CMAX)
NXGN vs CMAX Comparison August 2026
NextGen Healthcare, Inc. (NASDAQ: NXGN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGN stands at 1.6B. In comparison, CMAX has a market cap of 1.6M. Regarding current trading prices, NXGN is priced at $23.94 on the NASDAQ, while CMAX trades at $0.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGN currently has a P/E ratio of -266.00, whereas CMAX's P/E ratio is -0.00. In terms of profitability, NXGN's ROE is -0.01%, compared to CMAX's ROE of -2.01%. Regarding short-term risk, NXGN is more volatile compared to CMAX. This indicates higher risk in terms of short-term price fluctuations for NXGN.Check CMAX's competition here
VSee Health, Inc. (NASDAQ: VSEEW)
NXGN vs VSEEW Comparison August 2026
NextGen Healthcare, Inc. (NASDAQ: NXGN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGN stands at 1.6B. In comparison, VSEEW has a market cap of 1.4M. Regarding current trading prices, NXGN is priced at $23.94 on the NASDAQ, while VSEEW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGN currently has a P/E ratio of -266.00, whereas VSEEW's P/E ratio is -0.04. In terms of profitability, NXGN's ROE is -0.01%, compared to VSEEW's ROE of -115.71%. Regarding short-term risk, NXGN is less volatile compared to VSEEW. This indicates lower risk in terms of short-term price fluctuations for NXGN.Check VSEEW's competition here
Aclarion, Inc. (NASDAQ: ACON)
NXGN vs ACON Comparison August 2026
NextGen Healthcare, Inc. (NASDAQ: NXGN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGN stands at 1.6B. In comparison, ACON has a market cap of 1.3M. Regarding current trading prices, NXGN is priced at $23.94 on the NASDAQ, while ACON trades at $2.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGN currently has a P/E ratio of -266.00, whereas ACON's P/E ratio is -0.27. In terms of profitability, NXGN's ROE is -0.01%, compared to ACON's ROE of -0.59%. Regarding short-term risk, NXGN is less volatile compared to ACON. This indicates lower risk in terms of short-term price fluctuations for NXGN.Check ACON's competition here
MSP Recovery, Inc. (NASDAQ: LIFWZ)
NXGN vs LIFWZ Comparison August 2026
NextGen Healthcare, Inc. (NASDAQ: NXGN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGN stands at 1.6B. In comparison, LIFWZ has a market cap of 1.3M. Regarding current trading prices, NXGN is priced at $23.94 on the NASDAQ, while LIFWZ trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGN currently has a P/E ratio of -266.00, whereas LIFWZ's P/E ratio is N/A. In terms of profitability, NXGN's ROE is -0.01%, compared to LIFWZ's ROE of +1.56%. Regarding short-term risk, NXGN is more volatile compared to LIFWZ. This indicates higher risk in terms of short-term price fluctuations for NXGN.Check LIFWZ's competition here
EUDA Health Holdings Limited (NASDAQ: EUDAW)
NXGN vs EUDAW Comparison August 2026
NextGen Healthcare, Inc. (NASDAQ: NXGN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGN stands at 1.6B. In comparison, EUDAW has a market cap of 1.1M. Regarding current trading prices, NXGN is priced at $23.94 on the NASDAQ, while EUDAW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGN currently has a P/E ratio of -266.00, whereas EUDAW's P/E ratio is 0.04. In terms of profitability, NXGN's ROE is -0.01%, compared to EUDAW's ROE of +1.20%. Regarding short-term risk, NXGN is less volatile compared to EUDAW. This indicates lower risk in terms of short-term price fluctuations for NXGN.Check EUDAW's competition here
VSee Health, Inc. (NASDAQ: VSEE)
NXGN vs VSEE Comparison August 2026
NextGen Healthcare, Inc. (NASDAQ: NXGN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGN stands at 1.6B. In comparison, VSEE has a market cap of 816.5K. Regarding current trading prices, NXGN is priced at $23.94 on the NASDAQ, while VSEE trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGN currently has a P/E ratio of -266.00, whereas VSEE's P/E ratio is -0.10. In terms of profitability, NXGN's ROE is -0.01%, compared to VSEE's ROE of -115.71%. Regarding short-term risk, NXGN is less volatile compared to VSEE. This indicates lower risk in terms of short-term price fluctuations for NXGN.Check VSEE's competition here
MSP Recovery, Inc. (NASDAQ: MSPRZ)
NXGN vs MSPRZ Comparison August 2026
NextGen Healthcare, Inc. (NASDAQ: NXGN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGN stands at 1.6B. In comparison, MSPRZ has a market cap of 550.4K. Regarding current trading prices, NXGN is priced at $23.94 on the NASDAQ, while MSPRZ trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGN currently has a P/E ratio of -266.00, whereas MSPRZ's P/E ratio is N/A. In terms of profitability, NXGN's ROE is -0.01%, compared to MSPRZ's ROE of +1.56%. Regarding short-term risk, NXGN is less volatile compared to MSPRZ. This indicates lower risk in terms of short-term price fluctuations for NXGN.Check MSPRZ's competition here
Akerna Corp. (NASDAQ: KERN)
NXGN vs KERN Comparison August 2026
NextGen Healthcare, Inc. (NASDAQ: NXGN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGN stands at 1.6B. In comparison, KERN has a market cap of 162.3K. Regarding current trading prices, NXGN is priced at $23.94 on the NASDAQ, while KERN trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGN currently has a P/E ratio of -266.00, whereas KERN's P/E ratio is -0.01. In terms of profitability, NXGN's ROE is -0.01%, compared to KERN's ROE of -0.20%. Regarding short-term risk, NXGN is less volatile compared to KERN. This indicates lower risk in terms of short-term price fluctuations for NXGN.Check KERN's competition here
Akerna Corp. (NASDAQ: KERNW)
NXGN vs KERNW Comparison August 2026
NextGen Healthcare, Inc. (NASDAQ: NXGN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGN stands at 1.6B. In comparison, KERNW has a market cap of 162.3K. Regarding current trading prices, NXGN is priced at $23.94 on the NASDAQ, while KERNW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGN currently has a P/E ratio of -266.00, whereas KERNW's P/E ratio is -0.00. In terms of profitability, NXGN's ROE is -0.01%, compared to KERNW's ROE of -0.20%. Regarding short-term risk, NXGN is less volatile compared to KERNW. This indicates lower risk in terms of short-term price fluctuations for NXGN.Check KERNW's competition here
MSP Recovery, Inc. (NASDAQ: LIFWW)
NXGN vs LIFWW Comparison August 2026
NextGen Healthcare, Inc. (NASDAQ: NXGN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGN stands at 1.6B. In comparison, LIFWW has a market cap of 60.1K. Regarding current trading prices, NXGN is priced at $23.94 on the NASDAQ, while LIFWW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGN currently has a P/E ratio of -266.00, whereas LIFWW's P/E ratio is N/A. In terms of profitability, NXGN's ROE is -0.01%, compared to LIFWW's ROE of +1.56%. Regarding short-term risk, NXGN is more volatile compared to LIFWW. This indicates higher risk in terms of short-term price fluctuations for NXGN.Check LIFWW's competition here
CareMax, Inc. (NASDAQ: CMAXW)
NXGN vs CMAXW Comparison August 2026
NextGen Healthcare, Inc. (NASDAQ: NXGN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGN stands at 1.6B. In comparison, CMAXW has a market cap of 36.4K. Regarding current trading prices, NXGN is priced at $23.94 on the NASDAQ, while CMAXW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGN currently has a P/E ratio of -266.00, whereas CMAXW's P/E ratio is N/A. In terms of profitability, NXGN's ROE is -0.01%, compared to CMAXW's ROE of -2.01%. Regarding short-term risk, NXGN is more volatile compared to CMAXW. This indicates higher risk in terms of short-term price fluctuations for NXGN.Check CMAXW's competition here
Zhongchao Inc. (NASDAQ: ZCMD)
NXGN vs ZCMD Comparison August 2026
NextGen Healthcare, Inc. (NASDAQ: NXGN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGN stands at 1.6B. In comparison, ZCMD has a market cap of 35.3K. Regarding current trading prices, NXGN is priced at $23.94 on the NASDAQ, while ZCMD trades at $1.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGN currently has a P/E ratio of -266.00, whereas ZCMD's P/E ratio is -0.03. In terms of profitability, NXGN's ROE is -0.01%, compared to ZCMD's ROE of -0.32%. Regarding short-term risk, NXGN is less volatile compared to ZCMD. This indicates lower risk in terms of short-term price fluctuations for NXGN.Check ZCMD's competition here
Aclarion, Inc. (NASDAQ: ACONW)
NXGN vs ACONW Comparison August 2026
NextGen Healthcare, Inc. (NASDAQ: NXGN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGN stands at 1.6B. In comparison, ACONW has a market cap of 16K. Regarding current trading prices, NXGN is priced at $23.94 on the NASDAQ, while ACONW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGN currently has a P/E ratio of -266.00, whereas ACONW's P/E ratio is N/A. In terms of profitability, NXGN's ROE is -0.01%, compared to ACONW's ROE of -0.59%. Regarding short-term risk, NXGN is less volatile compared to ACONW. This indicates lower risk in terms of short-term price fluctuations for NXGN.Check ACONW's competition here
GeneDx Holdings Corp. (NASDAQ: WGSWW)
NXGN vs WGSWW Comparison August 2026
NextGen Healthcare, Inc. (NASDAQ: NXGN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGN stands at 1.6B. In comparison, WGSWW has a market cap of 5.8K. Regarding current trading prices, NXGN is priced at $23.94 on the NASDAQ, while WGSWW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGN currently has a P/E ratio of -266.00, whereas WGSWW's P/E ratio is -0.00. In terms of profitability, NXGN's ROE is -0.01%, compared to WGSWW's ROE of -0.39%. Regarding short-term risk, NXGN is more volatile compared to WGSWW. This indicates higher risk in terms of short-term price fluctuations for NXGN.Check WGSWW's competition here
CareCloud, Inc. (NASDAQ: MTBCO)
NXGN vs MTBCO Comparison August 2026
NextGen Healthcare, Inc. (NASDAQ: NXGN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGN stands at 1.6B. In comparison, MTBCO has a market cap of 0. Regarding current trading prices, NXGN is priced at $23.94 on the NASDAQ, while MTBCO trades at $25.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGN currently has a P/E ratio of -266.00, whereas MTBCO's P/E ratio is N/A. In terms of profitability, NXGN's ROE is -0.01%, compared to MTBCO's ROE of +0.17%. Regarding short-term risk, NXGN is less volatile compared to MTBCO. This indicates lower risk in terms of short-term price fluctuations for NXGN.Check MTBCO's competition here
MSP Recovery, Inc. (NASDAQ: MSPRV)
NXGN vs MSPRV Comparison August 2026
NextGen Healthcare, Inc. (NASDAQ: NXGN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGN stands at 1.6B. In comparison, MSPRV has a market cap of 0. Regarding current trading prices, NXGN is priced at $23.94 on the NASDAQ, while MSPRV trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGN currently has a P/E ratio of -266.00, whereas MSPRV's P/E ratio is N/A. In terms of profitability, NXGN's ROE is -0.01%, compared to MSPRV's ROE of N/A. Regarding short-term risk, NXGN is less volatile compared to MSPRV. This indicates lower risk in terms of short-term price fluctuations for NXGN.Check MSPRV's competition here
Convey Health Solutions Holdings, Inc. (NYSE: CNVY)
NXGN vs CNVY Comparison August 2026
NextGen Healthcare, Inc. (NASDAQ: NXGN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGN stands at 1.6B. In comparison, CNVY has a market cap of 0. Regarding current trading prices, NXGN is priced at $23.94 on the NASDAQ, while CNVY trades at $10.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGN currently has a P/E ratio of -266.00, whereas CNVY's P/E ratio is -71.50. In terms of profitability, NXGN's ROE is -0.01%, compared to CNVY's ROE of -0.02%. Regarding short-term risk, NXGN is less volatile compared to CNVY. This indicates lower risk in terms of short-term price fluctuations for NXGN.Check CNVY's competition here
Cerner Corporation (NASDAQ: CERN)
NXGN vs CERN Comparison August 2026
NextGen Healthcare, Inc. (NASDAQ: NXGN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGN stands at 1.6B. In comparison, CERN has a market cap of 0. Regarding current trading prices, NXGN is priced at $23.94 on the NASDAQ, while CERN trades at $94.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGN currently has a P/E ratio of -266.00, whereas CERN's P/E ratio is 55.84. In terms of profitability, NXGN's ROE is -0.01%, compared to CERN's ROE of +0.14%. Regarding short-term risk, NXGN is more volatile compared to CERN. This indicates higher risk in terms of short-term price fluctuations for NXGN.Check CERN's competition here
Alkuri Global Acquisition Corp. (NASDAQ: KURIU)
NXGN vs KURIU Comparison August 2026
NextGen Healthcare, Inc. (NASDAQ: NXGN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGN stands at 1.6B. In comparison, KURIU has a market cap of 0. Regarding current trading prices, NXGN is priced at $23.94 on the NASDAQ, while KURIU trades at $9.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGN currently has a P/E ratio of -266.00, whereas KURIU's P/E ratio is N/A. In terms of profitability, NXGN's ROE is -0.01%, compared to KURIU's ROE of +1.06%. Regarding short-term risk, NXGN is less volatile compared to KURIU. This indicates lower risk in terms of short-term price fluctuations for NXGN.Check KURIU's competition here
Sema4 Holdings Corp. (NASDAQ: SMFRW)
NXGN vs SMFRW Comparison August 2026
NextGen Healthcare, Inc. (NASDAQ: NXGN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGN stands at 1.6B. In comparison, SMFRW has a market cap of 0. Regarding current trading prices, NXGN is priced at $23.94 on the NASDAQ, while SMFRW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGN currently has a P/E ratio of -266.00, whereas SMFRW's P/E ratio is N/A. In terms of profitability, NXGN's ROE is -0.01%, compared to SMFRW's ROE of -0.39%. Regarding short-term risk, NXGN is less volatile compared to SMFRW. This indicates lower risk in terms of short-term price fluctuations for NXGN.Check SMFRW's competition here
CareCloud, Inc. (NASDAQ: MTBCP)
NXGN vs MTBCP Comparison August 2026
NextGen Healthcare, Inc. (NASDAQ: NXGN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGN stands at 1.6B. In comparison, MTBCP has a market cap of 0. Regarding current trading prices, NXGN is priced at $23.94 on the NASDAQ, while MTBCP trades at $26.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGN currently has a P/E ratio of -266.00, whereas MTBCP's P/E ratio is N/A. In terms of profitability, NXGN's ROE is -0.01%, compared to MTBCP's ROE of +0.17%. Regarding short-term risk, NXGN is less volatile compared to MTBCP. This indicates lower risk in terms of short-term price fluctuations for NXGN.Check MTBCP's competition here
IMS Health Holdings, Inc. (NYSE: IMS)
NXGN vs IMS Comparison August 2026
NextGen Healthcare, Inc. (NASDAQ: NXGN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGN stands at 1.6B. In comparison, IMS has a market cap of 0. Regarding current trading prices, NXGN is priced at $23.94 on the NASDAQ, while IMS trades at $31.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGN currently has a P/E ratio of -266.00, whereas IMS's P/E ratio is N/A. In terms of profitability, NXGN's ROE is -0.01%, compared to IMS's ROE of +0.27%. Regarding short-term risk, NXGN is less volatile compared to IMS. This indicates lower risk in terms of short-term price fluctuations for NXGN.Check IMS's competition here
Affymetrix, Inc. (NASDAQ: AFFX)
NXGN vs AFFX Comparison August 2026
NextGen Healthcare, Inc. (NASDAQ: NXGN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGN stands at 1.6B. In comparison, AFFX has a market cap of 0. Regarding current trading prices, NXGN is priced at $23.94 on the NASDAQ, while AFFX trades at $14.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGN currently has a P/E ratio of -266.00, whereas AFFX's P/E ratio is N/A. In terms of profitability, NXGN's ROE is -0.01%, compared to AFFX's ROE of +0.03%. Regarding short-term risk, NXGN is less volatile compared to AFFX. This indicates lower risk in terms of short-term price fluctuations for NXGN.Check AFFX's competition here
Nava Health MD, LLC (NASDAQ: NAVA)
NXGN vs NAVA Comparison August 2026
NextGen Healthcare, Inc. (NASDAQ: NXGN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGN stands at 1.6B. In comparison, NAVA has a market cap of 0. Regarding current trading prices, NXGN is priced at $23.94 on the NASDAQ, while NAVA trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGN currently has a P/E ratio of -266.00, whereas NAVA's P/E ratio is N/A. In terms of profitability, NXGN's ROE is -0.01%, compared to NAVA's ROE of +0.15%. Regarding short-term risk, NXGN is not fully comparable compared to NAVA. This indicates unavailable risk data in terms of short-term price fluctuations for NXGN.Check NAVA's competition here
Change Healthcare Inc. (NASDAQ: CHNGU)
NXGN vs CHNGU Comparison August 2026
NextGen Healthcare, Inc. (NASDAQ: NXGN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGN stands at 1.6B. In comparison, CHNGU has a market cap of 0. Regarding current trading prices, NXGN is priced at $23.94 on the NASDAQ, while CHNGU trades at $73.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGN currently has a P/E ratio of -266.00, whereas CHNGU's P/E ratio is N/A. In terms of profitability, NXGN's ROE is -0.01%, compared to CHNGU's ROE of -0.05%. Regarding short-term risk, NXGN is less volatile compared to CHNGU. This indicates lower risk in terms of short-term price fluctuations for NXGN.Check CHNGU's competition here
Change Healthcare Inc. (NASDAQ: CHNG)
NXGN vs CHNG Comparison August 2026
NextGen Healthcare, Inc. (NASDAQ: NXGN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGN stands at 1.6B. In comparison, CHNG has a market cap of 0. Regarding current trading prices, NXGN is priced at $23.94 on the NASDAQ, while CHNG trades at $27.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGN currently has a P/E ratio of -266.00, whereas CHNG's P/E ratio is -152.72. In terms of profitability, NXGN's ROE is -0.01%, compared to CHNG's ROE of -0.05%. Regarding short-term risk, NXGN is less volatile compared to CHNG. This indicates lower risk in terms of short-term price fluctuations for NXGN.Check CHNG's competition here
Castlight Health, Inc. (NYSE: CSLT)
NXGN vs CSLT Comparison August 2026
NextGen Healthcare, Inc. (NASDAQ: NXGN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGN stands at 1.6B. In comparison, CSLT has a market cap of 0. Regarding current trading prices, NXGN is priced at $23.94 on the NASDAQ, while CSLT trades at $2.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGN currently has a P/E ratio of -266.00, whereas CSLT's P/E ratio is -37.27. In terms of profitability, NXGN's ROE is -0.01%, compared to CSLT's ROE of -0.42%. Regarding short-term risk, NXGN is less volatile compared to CSLT. This indicates lower risk in terms of short-term price fluctuations for NXGN.Check CSLT's competition here
NantHealth, Inc. (NASDAQ: NH)
NXGN vs NH Comparison August 2026
NextGen Healthcare, Inc. (NASDAQ: NXGN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGN stands at 1.6B. In comparison, NH has a market cap of 0. Regarding current trading prices, NXGN is priced at $23.94 on the NASDAQ, while NH trades at $1.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGN currently has a P/E ratio of -266.00, whereas NH's P/E ratio is -0.12. In terms of profitability, NXGN's ROE is -0.01%, compared to NH's ROE of +0.35%. Regarding short-term risk, NXGN is less volatile compared to NH. This indicates lower risk in terms of short-term price fluctuations for NXGN.Check NH's competition here
CareCloud, Inc. (NASDAQ: MTBC)
NXGN vs MTBC Comparison August 2026
NextGen Healthcare, Inc. (NASDAQ: NXGN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGN stands at 1.6B. In comparison, MTBC has a market cap of 0. Regarding current trading prices, NXGN is priced at $23.94 on the NASDAQ, while MTBC trades at $3.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGN currently has a P/E ratio of -266.00, whereas MTBC's P/E ratio is N/A. In terms of profitability, NXGN's ROE is -0.01%, compared to MTBC's ROE of +0.19%. Regarding short-term risk, NXGN is less volatile compared to MTBC. This indicates lower risk in terms of short-term price fluctuations for NXGN.Check MTBC's competition here